Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Novilytic logo — The Canary in the Fermentor

Novilytic

The Canary in the Fermentor

Founded 2013 14 employees Seed Total: $1.80M Biotechnology, Health Care +1

General Information

Company Name Novilytic
Founded Year 2013
Employees 14
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Novilytic. To contact Novilytic, visit novilytic.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Novilytic compare?

A PDF of Novilytic and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Novilytic soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Novilytic

Novilytic LLC is a biotech startup with the slogan "The Canary in the Fermentor." Founded in 2013, the company is focused on monitoring the quality of life-saving medicines through nanotechnology and cutting-edge science for Process R&D and pharmaceutical manufacturing. The company's flagship technology, the Proteometer (Proteoform Meter), provides near-real-time warnings on molecular structure changes for drug development companies. This disruptive technology is sold in the form of kits, enabling customers to convert their LCs into a Proteometer quickly, with training and service remaining unchanged. The Proteometer was launched in February 2023, with plans for more innovative product launches in the coming year. Novilytic recently received a $1.80M Seed Round investment on May 3, 2022 from Elevate Ventures, Stateline Angels, and Purdue Foundry. With its focus on critical healthcare industries, Novilytic is poised for growth and continued impact in the biotech sector.

Business keywords: nanotechnology, pharmaceutical manufacturing, Process R&D, drug development, molecular structure, technology, Proteometer, LC conversion kits, service, innovation, product launches

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $1.80M 3
Elevate Ventures Stateline Angels
Elevate Ventures, Stateline Angels +1
03 May 2022

Novilytic Alternatives & Competitors

View All Alternatives
Novilytic vs
Bostal Drug Delivery
Bostal Drug Delivery

Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals sinc...

Series B
Biotechnology, Health Care
Novilytic vs
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics (Just China)

Empowering biomedicine with innovative design and cost-effective manufacturing.

Series B
201-500 employees
Biopharma, Biotechnology
Novilytic vs
OncoSolutions
OncoSolutions Ireland

CyCa OncoSolutions developed a nanomachine for drug delivery and cell labeling in Cork, Ireland.

Convertible Note
2-10 employees
Biotechnology, Health Care
View all alternatives

FAQ About Novilytic

The Canary in the Fermentor
Novilytic was founded in 2013.
Novilytic operates in Biotechnology, Health Care and Life Sciences. Its work centres on nanotechnology, pharmaceutical manufacturing, Process R&D and drug development.
Novilytic has approximately 14 employees.
Novilytic has completed 1 funding round, raising a total of $1.80M. The latest funding stage is Seed.
Top alternatives and competitors to Novilytic include Bostal Drug Delivery, Hangzhou Just Biotherapeutics (Just China), OncoSolutions, RedShiftBio, Genisphere. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Novilytic and Bostal Drug Delivery are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Novilytic, https://bouncewatch.com/company/novilytic-llc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout